2026 NPPES data Pulmonary Disease Physician NPI 1295735561 MD
Verify on CMS →

MICHAEL CHISDAK, MD

Pulmonary Disease Physician in JOHNSON CITY, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
2K
Medicare Part D claims · 387 beneficiaries · Pulmonary Disease Physician avg: 1K
Generic prescribing
31%
generic claims · 69% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
84.6352/100
▲ 2 pts above national avg 83.1 · [object Object]

What the federal data shows

MICHAEL CHISDAK, MD reported a CMS MIPS final score of 84.6352/100 — above the 83.1 national average — and filed 2,316 Medicare Part D claims in 2023.

84.6352/100
MIPS score · +2 vs avg
2K
Part D claims, 2023
31%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MICHAEL CHISDAK, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

85 45th percentile higher than 45% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). This entry sits in this band. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

MICHAEL CHISDAK, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about MICHAEL CHISDAK, MD?

Near national average

NPI registry status

Active

Issued 07/28/2005

NPI 1295735561

Primary specialty

Pulmonary Disease Physician

Mid-sized

9,271 US NPIs in this specialty

Medicare Part D claims

2,316 59% vs specialty avg

2023 prescription claims

Specialty avg: 1,457

MIPS final score

84.6352/100 1.5352000000000032% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in New York

How Pulmonary Disease Physician compares to other specialties among New York providers

New York providers

Pulmonary Disease Physician share within New York

1. Pulmonary Disease Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Pulmonary Disease Physician share within New York

Medicare quality performance — MIPS

MICHAEL CHISDAK, MD's 2023 MIPS final score plotted against the Pulmonary Disease Physician national average

Near national average
MIPS Final Score
84.6352/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Pulmonary Disease Physician) — 84.6352/100 vs national avg 83.1

0%100%National avg83%84.6%
MIPS final score (Pulmonary Disease Physician) — 84.6352/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MICHAEL CHISDAK, MD appears in the CMS NPPES registry as a Pulmonary Disease Physician provider holding MD credentials at 52 HARRISON ST, JOHNSON CITY, NY, 13790, with a listed phone of (607) 729-8845. NPI 1295735561 was issued on 07/28/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what CHISDAK most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 2,316 prescription claims written by this provider, covering 387 Medicare beneficiaries and totaling roughly $1.4 million in drug spend, split 69% brand-name and 31% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 84.6352/100 for the 2023 performance year (Quality 87.9613, Cost 54.4227), compared with the national average of 83.1.

Pulmonary Disease Physician is a mid-sized specialty nationwide, with 9,271 enrolled providers across 53 states and an average of 1,457 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

52 HARRISON ST
JOHNSON CITY, NY 13790

Provider Details

NPI 1295735561
Specialty Pulmonary Disease Physician
Credentials MD
Gender Male
NPI Issued 07/28/2005

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

84.6352
Final Score
Avg: 83.1
87.9613
Quality
54.4227
Cost
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where MICHAEL CHISDAK, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

UNITED HEALTH SERVICES HOSPITALS, INC.
JOHNSON CITY, NY

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to MICHAEL CHISDAK, MD. To verify MICHAEL CHISDAK, MD's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

MICHAEL CHISDAK, MD — brand share 69.0%
Specialty average (est.)

69% brand-name claims vs 31% generic, on 2,316 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

2,316
Total Claims
$1.4M
Total Drug Cost
387
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
3,525
Total Day Supply
99,472
Brand vs Generic
69% brand / 31% generic
Brand Drug Cost
$1.4M
Antibiotic Claims
134

Patient Demographics

Average Patient Age
71.5 years
Avg HCC Risk Score
1.60
Gender Split
57% female / 43% male
Age Distribution
<65: 64, 65-74: 166, 75-84: 135, 85+: 22

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What MICHAEL CHISDAK, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Albuterol Sulfate Hfa
Albuterol Sulfate
321
Trelegy Ellipta
Fluticasone/Umeclidin/Vilanter
178
Symbicort
Budesonide/Formoterol Fumarate
167
Flovent Hfa
Fluticasone Propionate
161
Prednisone
139
Spiriva Respimat
Tiotropium Bromide
105
Azithromycin
79
Breztri Aerosphere
Budesonide/Glycopyr/Formoterol
76
Breo Ellipta
Fluticasone/Vilanterol
71
Montelukast Sodium
69

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Pulmonary Disease Physician Overview

How MICHAEL CHISDAK, MD fits within the Pulmonary Disease Physician landscape nationally.

9,271
Pulmonary Disease Physician Providers in US
53
States with Pulmonary Disease Physician
1,457
Avg Claims per Provider

MICHAEL CHISDAK, MD's 2,316 claims are above the specialty average of 1,457.

Nearby Pulmonary Disease Physician Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as CHISDAK.

Compare Pulmonary Disease Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MICHAEL CHISDAK, MD's specialty?
MICHAEL CHISDAK, MD specializes in Pulmonary Disease Physician and practices in JOHNSON CITY, New York. Credentials: MD.
How much does MICHAEL CHISDAK, MD prescribe under Medicare Part D?
In 2023, MICHAEL CHISDAK, MD wrote 2,316 Medicare Part D claims totaling $1.4M in drug costs for 387 beneficiaries.
What is MICHAEL CHISDAK, MD's Medicare quality score?
MICHAEL CHISDAK, MD has a CMS MIPS Final Score of 84.6352/100 (Quality: 87.9613, Cost: 54.4227). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MICHAEL CHISDAK, MD located?
MICHAEL CHISDAK, MD is located at 52 HARRISON ST, JOHNSON CITY, NY, 13790. Phone: (607) 729-8845.
What is MICHAEL CHISDAK, MD's NPI number?
MICHAEL CHISDAK, MD's National Provider Identifier (NPI) is 1295735561, issued on 07/28/2005.
Does MICHAEL CHISDAK, MD prescribe more brand-name or generic drugs?
MICHAEL CHISDAK, MD's prescribing is 69% brand-name and 31% generic drugs by claim count, with $1.4M in brand drug costs.
How many Pulmonary Disease Physician providers are there in the US?
There are 9,271 Pulmonary Disease Physician providers across 53 states in the US. The average Pulmonary Disease Physician provider writes 1,457 Medicare Part D claims per year.
What drugs does MICHAEL CHISDAK, MD prescribe most often?
Based on 2023 Medicare Part D data, MICHAEL CHISDAK, MD's most frequently prescribed drugs include Albuterol Sulfate Hfa, Trelegy Ellipta, Symbicort. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MICHAEL CHISDAK, MD accept Medicare?
MICHAEL CHISDAK, MD appears in CMS Medicare data with 2,316 Part D claims and 387 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MICHAEL CHISDAK, MD's credentials?
MICHAEL CHISDAK, MD's NPI is 1295735561 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology